Corporate Presentation Corporate Presentation Past Presentations Oral Tablet Vaccination to SARS-CoV-2 Induces Long Lasting Crossreactive Mucosal Antibody Responses in Humans – World Vaccine Congress 2022, Dr. Sean Tucker Potent Immune Responses to Norovirus G1.1 Evaluated in Elderly Subjects following Oral Tablet Delivery in a Phase 1 Placebo-Controlled Study – World Vaccine Congress 2022, Dr. James Cummings Mucosal rAd5 Immunization Against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in Non-Human Primates by Dr Becca Flitter Oral Tablet Vaccination to SARS-CoV-2 Induces Pan-coronavirus Nasal IgA Responses in Humans by Dr Sean Tucker Hold the Needles and the Ice – World Vaccine Congress 2021 Dr Sean Tucker The Importance of T-cell Responses for COVID-19 Vaccines by Dr Sean Tucker Americans tell pollsters they want an oral vaccine Vaxart’s Oral COVID vaccine candidate: An easy pill to swallow by Dr Sean Tucker New York Academy of Sciences
Oral Tablet Vaccination to SARS-CoV-2 Induces Long Lasting Crossreactive Mucosal Antibody Responses in Humans – World Vaccine Congress 2022, Dr. Sean Tucker
Potent Immune Responses to Norovirus G1.1 Evaluated in Elderly Subjects following Oral Tablet Delivery in a Phase 1 Placebo-Controlled Study – World Vaccine Congress 2022, Dr. James Cummings
Mucosal rAd5 Immunization Against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in Non-Human Primates by Dr Becca Flitter
Oral Tablet Vaccination to SARS-CoV-2 Induces Pan-coronavirus Nasal IgA Responses in Humans by Dr Sean Tucker
